Health

Results: 2233-2244 of 7456

AACR 2025: Crown Bioscience Unveils 3D Bone Marrow Niche In Vitro Models for Oncology Preclinical Screening in Hematological Malignancies

Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Anthem Blue Cross/Blue Shield

Progressive Supranuclear Palsy Phase 2 Platform Clinical Trial Announces the Selection of AADvac1 and AZP2006 for its First Two Regimens

HistoSonics’ Histotripsy System Demonstrates 90% Local Tumor Control at 12 Months in #HOPE4LIVER Trials

Alnylam Receives Positive CHMP Opinion for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy

PR Newswire associated0

Nature Communications Medicine Publishes Positive, Real World Data for Tinnitus Patients Treated with Unique, FDA Approved Stimulation Device

Ettore Sansavini, GVM Care & Research President, and Antonio Petralia, CEO and Executive Vice President of Eurosets, with Xtreme Rescue and Jetson One

Life-saving Technologies at EuroELSO 2025: Eurosets Presents Landing Breathe and Xtreme Rescue

EBC Financial Group Deepens Commitment to United to Beat Malaria with Renewed Global Partnership and First-Ever 5K Run Sponsorship

Konovo Launches: Unifying Three Market Research Leaders to Enable Faster, Better, Connected Insights

PR Newswire associated0

Bone Health: Biocon Biologics Receives Positive CHMP Opinions for Biosimilar Denosumab in Europe

PR Newswire associated0

Comac Medical Announces New Leadership Appointments and International Expansion

Bayer receives MHRA authorisation for Beyonttra® ▼ (acoramidis) as a new treatment of transthyretin amyloidosis in adult patients with cardiomyopathy